Vaccine update

January 1997
Mothering;Jan-Mar97, Issue 82, p33
Presents an update on vaccines for children, as of January 1997. US Food and Drug Administration's licensing of an acellular pertussis vaccine for babies under 18 months of age; Centers for Disease Control and Prevention's recommendation of the use of injectable inactivated polio vaccine; Availability of the workshop summary of the Vaccine Safety Forum `Options for Poliomyelitis Vaccination in the United States.'


Related Articles

  • Safer shots. Hutter, Sarah // Working Mother;Dec96, p66 

    Presents updates on three effective vaccines available in the United States. Four-dose oral polio vaccine; Hepatitis A vaccine called Vaqta; Tripedie DTaP vaccine for whooping cough.

  • Satellite videoconference on pertussis and poliovirus vaccines.  // JAMA: Journal of the American Medical Association;2/5/97, Vol. 277 Issue 5, p372 

    Offers an update on a 1997 videoconference about pertussis and poliovirus vaccines. Who is sponsoring the videoconference besides the US Centers for Disease Control and Prevention; Topics scheduled for discussion.

  • Estimating vaccination coverage using parental recall, vaccination cards, and medical records. BOLTON, PAUL; HOLT, ELIZABETH; ROSS, ALAN; HUGHART, NANCY; GUYER, BERNARD // Public Health Reports;Nov/Dec98, Vol. 113 Issue 6, p521 

    Compares estimates based on vaccination cards, parental recall and medical records of the percentages of children up-to-date on vaccinations for diphtheria, tetanus and pertussis, polio, measles, mumps and rubella. Methodology; Results; Data-analysis.

  • Reply. Vashishtha, Vipin // Indian Pediatrics;Dec2012, Vol. 49 Issue 12, p996 

    A reply is presented which clarified the administration of oral polio vaccine (OVP) after inactivated polio vaccine (IPV), which was recommended by the Indian Academy of Pediatrics Committee on Immunization (IAPCOI). The committee cautions the reduction of the quantity of whole cell pertussis...

  • Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule. Avdicová, Mária; Prikazský, Viktor; Hudecková, Henrieta; Schuerman, Lode; Willems, Paul // European Journal of Pediatrics;2002, Vol. 161 Issue 11, p581 

    In an open randomised trial, 312 eligible infants were enrolled to receive either a single injection of the hexavalent diphtheria-tetanus-acellular pertussishepatitis B virus-inactivated polio/Haemophilus influenzae b (DTPa-HBV-IPV/Hib) vaccine, or concomitant injections of commercial...

  • DTPa-HBV-IPV/Hib Vaccine (Infanrix hexaâ„¢): A Guide to Its Use in Infants. Lyseng-Williamson, Katherine A.; Dhillon, Sohita // Pediatric Drugs;2012, Vol. 14 Issue 5, p337 

    Infanrix hexaâ„¢, a diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliomyelitis, and Haemophilus influenzae type b (Hib) conjugate vaccine, is indicated for primary and booster vaccination of infants. Available clinical data from more than a decade of experience with the...

  • DTaP5-IPV-Hib Vaccine (Pediacel®). Frampton, James E. // Pediatric Drugs;2011, Vol. 13 Issue 6, p401 

    Pediacel® is a fully liquid formulation of a diphtheria, tetanus, five-component acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b combination vaccine, which does not require reconstitution. Both vial and prefilled syringe presentations of Pediacel® are...

  • In The News: UK 5-in-1 baby vaccine. Minton, Kirsty // Nature Reviews Immunology;Sep2004, Vol. 4 Issue 9, p659 

    Reports on the implementation of a 5-in-1 vaccine against diphtheria, tetanus, pertussis, Hib and polio for babies of more than two months of age in Great Britain starting September 2004. Changes made to the current protocol; Reason the pertussis component is being switched from a whole-cell...

  • Temporary shortage of DPTP-Hib. Comeau, Pauline // CMAJ: Canadian Medical Association Journal;10/26/2004, Vol. 171 Issue 9, p1030 

    Reports on the temporary shortage of the Pentacel vaccine for diphtheria, pertussis, tetanus, polio (DPTP) and Haemophilus influenzae type b (Hib) in Canada as of October 2004. Outcome of the shortage in DPTP-Hib vaccines; Efforts of Health Canada to address the shortage of the Pentacel...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics